Zogenix, Inc. (ZGNX)

ZGNX was delisted on the 4th of March, 2022.

• Market cap: $1.5B
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Zogenix Inc is engaged in developing and commercializing therapeutic solutions for people living with serious and life-threatening rare CNS disorders and medical conditions. Its product candidate includes ZX008, low-dose fenfluramine for the treatment of Dravet syndrome, LGS, and potentially other rare and catastrophic epilepsy disorders.

Employees: 327